Logo
x

Search

Subscribe Now

Cell Lung Cancer

Roche's Tecentriq Receives CHMP's Positive Opinion for 1L Treatment for Metastatic Non-Small Cell Lung Cancer

Roche's Tecentriq Receives CHMP's Positive Opinion for 1L Treatment for Metastatic Non-Small Cell Lung Cancer

  • March 29, 2021
AstraZeneca Signs an Agreement with ArcherDX for Utilizing Personalized Cancer Assays to Detect MRD in Patients with Early-Stage Non-Small Cell Lung Cancer

AstraZeneca Signs an Agreement with ArcherDX for Utilizing Personalized Cancer Assays to Detect MRD in Patients with Early-Stage N...

  • May 26, 2020
Roche's Tecentriq Receives the US FDA's Approval as 1L Monotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Roche's Tecentriq Receives the US FDA's Approval as 1L Monotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

  • May 19, 2020
Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Breakthrough Therapy Designation for HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Breakthrough Therapy Designation f...

  • May 18, 2020
Roche to Present Results of Tiragolumab in P-II CITYSCAPE Study for Non-Small Cell Lung Cancer at ASCO20

Roche to Present Results of Tiragolumab in P-II CITYSCAPE Study for Non-Small Cell Lung Cancer at ASCO20

  • May 14, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.